78 results on '"Baiges, Anna"'
Search Results
2. Hipertensión portal: recomendaciones de diagnóstico y tratamiento. Documento de consenso de la Asociación Española para el Estudio del Hígado (AEEH) y el Centro para la Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd)
3. Porto-sinusoidal vascular liver disorder with portal hypertension: Natural history and long-term outcome
4. Impact of SARS-CoV-2 vaccination in patients with vascular liver diseases: Observations from a VALDIG multicenter study
5. Persistent varices in cured patients: Understanding the role of hepatic venous pressure gradient
6. Portal vein thrombosis: diagnosis, management, and endpoints for future clinical studies
7. Porto-sinusoidal vascular disorder in chronic HBV: A significant coexistence not to be overlooked
8. Evolution of spontaneous portosystemic shunts over time and following aetiological intervention in patients with cirrhosis
9. Splanchnic vein thrombosis associated with SARS-CoV-2 infection: A VALDIG case–control study
10. Incidence and factors predictive of recurrent thrombosis in people with non-cirrhotic portal vein thrombosis
11. Non-invasive tests for clinically significant portal hypertension after HCV cure
12. The portal vein in patients with cirrhosis is not an excessively inflammatory or hypercoagulable vascular bed, a prospective cohort study
13. Impact of SARS-CoV-2 Pandemic on Vascular Liver Diseases
14. Baveno VII – Renewing consensus in portal hypertension
15. Predicting portal thrombosis in cirrhosis: A prospective study of clinical, ultrasonographic and hemostatic factors
16. Co-expression gene network analysis reveals novel regulatory pathways involved in porto-sinusoidal vascular disease
17. Treatment of Acute Variceal Bleeding in 2021—When to Use Transjugular Intrahepatic Portosystemic Shunts?
18. Next-generation sequencing in the diagnosis of non-cirrhotic splanchnic vein thrombosis
19. Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: a Meta-analysis of Individual Patient Data
20. Clinical outcome and hemodynamic changes following HCV eradication with oral antiviral therapy in patients with clinically significant portal hypertension
21. Total area of spontaneous portosystemic shunts independently predicts hepatic encephalopathy and mortality in liver cirrhosis
22. Precision medicine in variceal bleeding: Are we there yet?
23. Prevalence, features and predictive factors of liver nodules in Fontan surgery patients: The VALDIG Fonliver prospective cohort
24. Association Between Portosystemic Shunts and Increased Complications and Mortality in Patients With Cirrhosis
25. Effects of All-Oral Anti-Viral Therapy on HVPG and Systemic Hemodynamics in Patients With Hepatitis C Virus-Associated Cirrhosis
26. Timing Affects Measurement of Portal Pressure Gradient After Placement of Transjugular Intrahepatic Portosystemic Shunts in Patients With Portal Hypertension
27. Nonendoscopic management of acute esophageal variceal bleeding
28. Early transjugular intrahepatic portosystemic shunt: When, how and in whom?
29. Derivación portosistémica intrahepática transyugular precoz: cuándo, cómo y a quién
30. Severe acute kidney injury associated with non-steroidal anti-inflammatory drugs in cirrhosis: A case-control study
31. Role of calreticulin mutations in the aetiological diagnosis of splanchnic vein thrombosis
32. Endoscopic Hemostasis in Acute Esophageal Variceal Bleeding
33. THU-295 - Recent splanchnic vein thrombosis occurring during Sars-Cov-2 infection-The VALDIG study
34. Chapter 5 - Obstruction of the liver circulation
35. SAT-123 Evaluation of portal hemodynamics after etiological factor removal and persistence of varices in patients with an HVPG
36. SAT-074 Hemodynamic profile of terlipressin and octreotide in patients with cirrhosis and portal hypertension. A randomized, double-blind clinical trial
37. OS-081 Portal vein recanalization in non-cirrhotic patients with portal vein occlusion: first results of a VALDIG study
38. Impacto de la investigación sistemática de estreptococo del grupo B en orina en la identificación de gestantes colonizadas
39. THU-308 - Chronic hepatitis B infection and porto-sinusoidal vascular disorder, a non-negligible coexistence
40. THU-290 - Efficacy and safety of vaccination againts SARS-CoV-2 in patients with vascular liver disease
41. FRI-499 - Liver elastography is a useful technique to assess the severity of liver congestion in patients with Budd-Chiari syndrome
42. OS-123-YI - Porto sinusoidal vascular liver disorder: natural history and long-term outcome
43. GS-003 - Rivaroxaban improves survival and decompensation in cirrhotic patients with moderate liver dysfunction. Double-blind, placebo-controlled trial
44. Reply to: “Factor VIII as a potential predictor of recurrent thrombosis in patients with non-cirrhotic portal vein thrombosis”
45. Integrones de clase 1 en aislados de Salmonella enterica productores de diferentes tipos de betalactamasas recogidos en la región sanitaria de Tortosa
46. 15 - Portal Hypertensive Bleeding
47. Management of gastric varices: still a matter of debate?
48. FRI265 - New cases of Budd-Chiari syndrome and splanchnic vein thrombosis after COVID-19 vaccination-a vascular liver disease group (VALDIG) initiative
49. THU542 - The portal vein in patients with cirrhosis is not an extensively inflammatory or hypercoagulable vascular bed
50. OS127 - Non-invasive tests for clinically significant portal hypertension after HCV-cure-individual patient data meta-analysis and validation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.